Key result
ML277 and C28 rescue β-adrenergic response in LQT1 mutants by enhancing KCNQ1 open state occupancy.
Why the study?
The underlying mechanism of beta-adrenergic stimulation of IKs remains unclear, impeding the development of new therapeutics for LQT1.
Enhancing the fully activated open state occupancy of the KCNQ1 channel represents a potential novel antiarrhythmic strategy to rescue the response to β-adrenergic stimulation in LQT1 mutants.
Does not support clinical use in LQT1; leaves open whether KCNQ1 modulators translate beyond animal models.
The cardiac KCNQ1 + KCNE1 (IKs) channel regulates heart rhythm under both normal and stress conditions. Under stress, the β-adrenergic stimulation elevates the intracellular cyclic adenosine monophosphate (cAMP) level, leading to KCNQ1 phosphorylation by protein kinase A and increased IKs, which shortens action potentials to adapt to accelerated heart rate. An impaired response to the β-adrenergic stimulation due to KCNQ1 mutations is associated with the occurrence of a lethal congenital long QT syndrome (type 1, also known as LQT1). However, the underlying mechanism of β-adrenergic stimulation of IKs remains unclear, impeding the development of new therapeutics. Here, we find that the unique properties of KCNQ1 channel gating with two distinct open states are key to this mechanism. KCNQ1's fully activated open (AO) state is more sensitive to cAMP than its intermediate open state. By enhancing the AO state occupancy, the small molecules ML277 and C28 are found to effectively enhance the cAMP sensitivity of the KCNQ1 channel, independent of KCNE1 association. This finding of enhancing AO state occupancy leads to a potential novel strategy to rescue the response of IKs to β-adrenergic stimulation in LQT1 mutants. The success of this approach is demonstrated in cardiac myocytes and also in a high-risk LQT1 mutation. In conclusion, the present study not only uncovers the key role of the AO state in IKs channel phosphorylation, but also provides a target for antiarrhythmic strategy.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2024) studied Long QT syndrome type 1 (LQT1). ML277 and C28 (small molecules) was evaluated on cAMP sensitivity and response of IKs to β-adrenergic stimulation. Enhancing the fully activated open state occupancy of KCNQ1 with small molecules ML277 and C28 increased cAMP sensitivity, rescuing the response to β-adrenergic stimulation in LQT1 mutants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: